Relying On Perfection In An Imperfect World: ADHD Drug Shortage Could Spur Push For DEA Reform
Ongoing stimulant shortages leads to calls for DEA to allow for more elasticity in the supply chains of drugs with potential for abuse, but in wake of ongoing opioid crisis agency appears willing to potentially shift but not up quotas.
You may also be interested in...
Teva, one of the largest manufacturers and suppliers of branded and generic Adderall, the renowned treatment for ADHD and narcolepsy, has responded to claims.
A spike in demand for Adderall and its generic versions has left patients scrambling to have their prescriptions filled, making headline news in the US. Leading generics manufacturer Sandoz told Generics Bulletin its current experience amid the supply squeeze.
A move to cut senior FDA positions including CDER Director through the appropriations process is rare and almost certain to fail, but experts say the attempt is indicative of an environment that seems to be encouraging these personal amendments.